911³Ô¹Ï

911³Ô¹Ï Researchers Receive Grant to Support Collaborative Study on the Brain Mechanics of Escape

Palm Health Foundation has pledged $500,000 toward the launch of the Center for the Resilient Mind at 911³Ô¹Ï's Stiles-Nicholson Brain Institute (SNBI).

911³Ô¹Ï's Charles E. Schmidt College of Medicine recently hosted the summit, bringing together top scientists from North America and Europe to discuss the latest amyloid research and advancements.

A breakthrough by 911³Ô¹Ï researchers shows that blocking the kappa opioid receptor improves behavioral deficits tied to ADHD, autism and bipolar disorder, providing a potentially safer yet effective treatment.

911³Ô¹Ï Jupiter’s Multi-institute Research Hub Hosts Joint Event to Celebrate Biomedical Research Driven by the Next Generation of Scientists

Stiles-Nicholson Brain Institute Marks Opening of Neurodegenerative Disease Research Center

911³Ô¹Ï's Stiles-Nicholson Brain Institute will celebrate advancements in brain science and health with its annual "Brainy Days" events throughout the month of March.

911³Ô¹Ï researchers have developed cutting-edge fluorescent cholesterol probes, which now enable them to visualize cholesterol movement and distribution in live cells with unprecedented detail.

911³Ô¹Ï neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system.

Randy D. Blakely, Ph.D., a highly regarded neuroscientist and pharmacologist, is among an extraordinary group selected by the American Society for Pharmacology and Experimental Therapeutics.